Intrapleural photodynamic therapy: Results of a phase I trial View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1994-01

AUTHORS

Harvey I. Pass, Thomas F. DeLaney, Zelig Tochner, Paul E. Smith, Barbara K. Temeck, Helen W. Pogrebniak, Karen C. Kranda, Angelo Russo, Walter S. Friauf, John W. Cole, James B. Mitchell, Gunter Thomas

ABSTRACT

Background: The management of pleural neoplasms, specifically mesothelioma, remains difficult. We performed a phase I trial in 54 patients with isolated hemithorax pleural malignancy to determine (a) the feasibility of intraoperative, intrapleural photodynamic therapy after debulking surgery; (b) the influence of light dose/sensitizer interval on postoperative morbidity in order to define the photodynamic therapy (PDT) maximal tolerated dose (MTD); and (c) whether first order dosimetry could be applied to this complex geometry.Methods: Cohorts of three patients were given escalating intraoperative light doses of 15–35 J/cm2 48 h after i.v. delivery of 2.0 mg/kg Photofrin II (Quadra Logic Technologies, Vancouver, British Columbia, Canada), and then escalating light doses of 30–32.5 J/cm2 after a 24-h sensitizer/operation interval. Twelve patients could not be debulked to the prerequisite 5 mm residual tumor thickness. The remaining 42 patients underwent 19 modified pleuropneumonectomies, five lobectomy-pleurectomies, and 18 pleurectomies. Intrapleural PDT was delivered using 630 nm light from two argon pump-dye lasers, and real-time and cumulative light doses were monitored using seven uniquely designed, computer-interfaced photodiodes.Results: There was one 30-day mortality from intraoperative hemorrhage. In the 48-h sensitizer/operation group (n=33), possible PDT-related complications included an empyema with late hemorrhage in one of three patients at 17.5 J/cm2 and a bronchopleural fistula at 35 J/cm2. At each of these light doses, three additional patients were treated without complication. Two patients subjected to 24-h sensitizer dosing and 32.5 J/cm2 developed esophageal perforations after pleuropneumonectomy at identical sites. The MTD was declared as 30 J/cm2 light with a 24-h dosing interval when none of the six patients (three original, three repeat) at that level developed toxicity.Conclusions: These data demonstrate that resection and intrapleural PDT can be performed safely with currently available sensitizers and lasers. Phase II and III trials are now warranted at this MTD in a homogeneous population of patients with pleural malignancies. More... »

PAGES

28-37

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/bf02303538

DOI

http://dx.doi.org/10.1007/bf02303538

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1003120273

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/7834425


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Combined Modality Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mesothelioma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Photochemotherapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pleural Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Rate", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Thoracic Oncology Section, Surgery Branch, National Cancer Institute, National Institutes of Health, Building 10, Room 2B07, 20892, Bethesda, MD, USA", 
          "id": "http://www.grid.ac/institutes/grid.48336.3a", 
          "name": [
            "Thoracic Oncology Section, Surgery Branch, National Cancer Institute, National Institutes of Health, Building 10, Room 2B07, 20892, Bethesda, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pass", 
        "givenName": "Harvey I.", 
        "id": "sg:person.0763326335.92", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0763326335.92"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Radiation Oncology Branch and Experimental Phototherapy Section, National Cancer Institute, National Institutes of Health, USA", 
          "id": "http://www.grid.ac/institutes/grid.48336.3a", 
          "name": [
            "Radiation Oncology Branch and Experimental Phototherapy Section, National Cancer Institute, National Institutes of Health, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "DeLaney", 
        "givenName": "Thomas F.", 
        "id": "sg:person.011105000337.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011105000337.49"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Radiation Oncology Branch and Experimental Phototherapy Section, National Cancer Institute, National Institutes of Health, USA", 
          "id": "http://www.grid.ac/institutes/grid.48336.3a", 
          "name": [
            "Radiation Oncology Branch and Experimental Phototherapy Section, National Cancer Institute, National Institutes of Health, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tochner", 
        "givenName": "Zelig", 
        "id": "sg:person.053570030.30", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.053570030.30"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Biomedical Engineering and Instrumentation Program, National Center for Research Resources, National Institutes of Health, Bethesda, Maryland, USA", 
          "id": "http://www.grid.ac/institutes/grid.94365.3d", 
          "name": [
            "Biomedical Engineering and Instrumentation Program, National Center for Research Resources, National Institutes of Health, Bethesda, Maryland, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Smith", 
        "givenName": "Paul E.", 
        "id": "sg:person.012561650317.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012561650317.13"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Thoracic Oncology Section, Surgery Branch, National Cancer Institute, National Institutes of Health, Building 10, Room 2B07, 20892, Bethesda, MD, USA", 
          "id": "http://www.grid.ac/institutes/grid.48336.3a", 
          "name": [
            "Thoracic Oncology Section, Surgery Branch, National Cancer Institute, National Institutes of Health, Building 10, Room 2B07, 20892, Bethesda, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Temeck", 
        "givenName": "Barbara K.", 
        "id": "sg:person.01306041342.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01306041342.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Thoracic Oncology Section, Surgery Branch, National Cancer Institute, National Institutes of Health, Building 10, Room 2B07, 20892, Bethesda, MD, USA", 
          "id": "http://www.grid.ac/institutes/grid.48336.3a", 
          "name": [
            "Thoracic Oncology Section, Surgery Branch, National Cancer Institute, National Institutes of Health, Building 10, Room 2B07, 20892, Bethesda, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pogrebniak", 
        "givenName": "Helen W.", 
        "id": "sg:person.01223477320.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01223477320.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Thoracic Oncology Section, Surgery Branch, National Cancer Institute, National Institutes of Health, Building 10, Room 2B07, 20892, Bethesda, MD, USA", 
          "id": "http://www.grid.ac/institutes/grid.48336.3a", 
          "name": [
            "Thoracic Oncology Section, Surgery Branch, National Cancer Institute, National Institutes of Health, Building 10, Room 2B07, 20892, Bethesda, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kranda", 
        "givenName": "Karen C.", 
        "id": "sg:person.01032321717.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01032321717.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Radiation Oncology Branch and Experimental Phototherapy Section, National Cancer Institute, National Institutes of Health, USA", 
          "id": "http://www.grid.ac/institutes/grid.48336.3a", 
          "name": [
            "Radiation Oncology Branch and Experimental Phototherapy Section, National Cancer Institute, National Institutes of Health, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Russo", 
        "givenName": "Angelo", 
        "id": "sg:person.01046205245.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01046205245.21"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Biomedical Engineering and Instrumentation Program, National Center for Research Resources, National Institutes of Health, Bethesda, Maryland, USA", 
          "id": "http://www.grid.ac/institutes/grid.94365.3d", 
          "name": [
            "Biomedical Engineering and Instrumentation Program, National Center for Research Resources, National Institutes of Health, Bethesda, Maryland, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Friauf", 
        "givenName": "Walter S.", 
        "id": "sg:person.014401452607.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014401452607.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Biomedical Engineering and Instrumentation Program, National Center for Research Resources, National Institutes of Health, Bethesda, Maryland, USA", 
          "id": "http://www.grid.ac/institutes/grid.94365.3d", 
          "name": [
            "Biomedical Engineering and Instrumentation Program, National Center for Research Resources, National Institutes of Health, Bethesda, Maryland, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cole", 
        "givenName": "John W.", 
        "id": "sg:person.01211242634.96", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01211242634.96"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Radiation Oncology Branch and Experimental Phototherapy Section, National Cancer Institute, National Institutes of Health, USA", 
          "id": "http://www.grid.ac/institutes/grid.48336.3a", 
          "name": [
            "Radiation Oncology Branch and Experimental Phototherapy Section, National Cancer Institute, National Institutes of Health, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mitchell", 
        "givenName": "James B.", 
        "id": "sg:person.014251525642.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014251525642.48"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Radiation Oncology Branch and Experimental Phototherapy Section, National Cancer Institute, National Institutes of Health, USA", 
          "id": "http://www.grid.ac/institutes/grid.48336.3a", 
          "name": [
            "Radiation Oncology Branch and Experimental Phototherapy Section, National Cancer Institute, National Institutes of Health, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Thomas", 
        "givenName": "Gunter", 
        "id": "sg:person.07550762252.57", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07550762252.57"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "1994-01", 
    "datePublishedReg": "1994-01-01", 
    "description": "Background: The management of pleural neoplasms, specifically mesothelioma, remains difficult. We performed a phase I trial in 54 patients with isolated hemithorax pleural malignancy to determine (a) the feasibility of intraoperative, intrapleural photodynamic therapy after debulking surgery; (b) the influence of light dose/sensitizer interval on postoperative morbidity in order to define the photodynamic therapy (PDT) maximal tolerated dose (MTD); and (c) whether first order dosimetry could be applied to this complex geometry.Methods: Cohorts of three patients were given escalating intraoperative light doses of 15\u201335 J/cm2 48 h after i.v. delivery of 2.0 mg/kg Photofrin II (Quadra Logic Technologies, Vancouver, British Columbia, Canada), and then escalating light doses of 30\u201332.5 J/cm2 after a 24-h sensitizer/operation interval. Twelve patients could not be debulked to the prerequisite 5 mm residual tumor thickness. The remaining 42 patients underwent 19 modified pleuropneumonectomies, five lobectomy-pleurectomies, and 18 pleurectomies. Intrapleural PDT was delivered using 630 nm light from two argon pump-dye lasers, and real-time and cumulative light doses were monitored using seven uniquely designed, computer-interfaced photodiodes.Results: There was one 30-day mortality from intraoperative hemorrhage. In the 48-h sensitizer/operation group (n=33), possible PDT-related complications included an empyema with late hemorrhage in one of three patients at 17.5 J/cm2 and a bronchopleural fistula at 35 J/cm2. At each of these light doses, three additional patients were treated without complication. Two patients subjected to 24-h sensitizer dosing and 32.5 J/cm2 developed esophageal perforations after pleuropneumonectomy at identical sites. The MTD was declared as 30 J/cm2 light with a 24-h dosing interval when none of the six patients (three original, three repeat) at that level developed toxicity.Conclusions: These data demonstrate that resection and intrapleural PDT can be performed safely with currently available sensitizers and lasers. Phase II and III trials are now warranted at this MTD in a homogeneous population of patients with pleural malignancies.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/bf02303538", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1105545", 
        "issn": [
          "1068-9265", 
          "1534-4681"
        ], 
        "name": "Annals of Surgical Oncology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "1"
      }
    ], 
    "keywords": [
      "phase I trial", 
      "pleural malignancy", 
      "light doses", 
      "residual tumor thickness", 
      "intrapleural photodynamic therapy", 
      "postoperative morbidity", 
      "late hemorrhage", 
      "esophageal perforation", 
      "intraoperative hemorrhage", 
      "bronchopleural fistula", 
      "additional patients", 
      "tumor thickness", 
      "operation group", 
      "pleural neoplasms", 
      "patients", 
      "doses", 
      "trials", 
      "pleuropneumonectomy", 
      "phase II", 
      "hemorrhage", 
      "complications", 
      "Photofrin II", 
      "malignancy", 
      "MTD", 
      "photodynamic therapy", 
      "homogeneous population", 
      "cm2 light", 
      "intervals", 
      "morbidity", 
      "pleurectomy", 
      "empyema", 
      "resection", 
      "fistula", 
      "surgery", 
      "neoplasms", 
      "mesothelioma", 
      "therapy", 
      "PDT", 
      "cohort", 
      "mortality", 
      "perforation", 
      "dose", 
      "available sensitizers", 
      "toxicity", 
      "maximal", 
      "identical sites", 
      "delivery", 
      "group", 
      "population", 
      "sensitizers", 
      "management", 
      "levels", 
      "dosimetry", 
      "operation interval", 
      "data", 
      "sites", 
      "feasibility", 
      "prerequisite", 
      "results", 
      "light", 
      "influence", 
      "thickness", 
      "cm2", 
      "laser", 
      "order", 
      "geometry", 
      "complex geometries", 
      "photodiodes", 
      "I trial", 
      "hemithorax pleural malignancy", 
      "light dose/sensitizer interval", 
      "dose/sensitizer interval", 
      "sensitizer interval", 
      "photodynamic therapy (PDT) maximal", 
      "therapy (PDT) maximal", 
      "first order dosimetry", 
      "order dosimetry", 
      "intraoperative light doses", 
      "cm2 48 h", 
      "sensitizer/operation interval", 
      "Intrapleural PDT", 
      "argon pump-dye lasers", 
      "pump-dye lasers", 
      "cumulative light doses", 
      "computer-interfaced photodiodes", 
      "sensitizer/operation group", 
      "possible PDT-related complications", 
      "PDT-related complications"
    ], 
    "name": "Intrapleural photodynamic therapy: Results of a phase I trial", 
    "pagination": "28-37", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1003120273"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/bf02303538"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "7834425"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/bf02303538", 
      "https://app.dimensions.ai/details/publication/pub.1003120273"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:05", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_231.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/bf02303538"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf02303538'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf02303538'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf02303538'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf02303538'


 

This table displays all metadata directly associated to this object as RDF triples.

276 TRIPLES      21 PREDICATES      126 URIs      118 LITERALS      18 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/bf02303538 schema:about N0eafb89b5b6d4f629f27d497bf32071b
2 N532dbe55ea1a4c47b03edbef9e57fbd9
3 N6ceb4c3d510f41c398ae676c917f527d
4 N73f80eb4a8424c36a12155a653aa6790
5 N7850e9483cef440ca7d5fbc61b1ba4c0
6 N971df54ff2954d56a8221fc300fa8cf2
7 Nc57dc31b85b24840908e02f4cfe6691d
8 Nc584f38c3cb6415e9faf7cd72e149804
9 Ndec3bc1ce30442748b0140b6c2568acd
10 Nea1acc095a354a209576c531a7afe760
11 Neb573f6b0e36485fad30fd1f4ce6b601
12 anzsrc-for:11
13 anzsrc-for:1103
14 schema:author N3964bade072e4d908dd84bd605567747
15 schema:datePublished 1994-01
16 schema:datePublishedReg 1994-01-01
17 schema:description Background: The management of pleural neoplasms, specifically mesothelioma, remains difficult. We performed a phase I trial in 54 patients with isolated hemithorax pleural malignancy to determine (a) the feasibility of intraoperative, intrapleural photodynamic therapy after debulking surgery; (b) the influence of light dose/sensitizer interval on postoperative morbidity in order to define the photodynamic therapy (PDT) maximal tolerated dose (MTD); and (c) whether first order dosimetry could be applied to this complex geometry.Methods: Cohorts of three patients were given escalating intraoperative light doses of 15–35 J/cm2 48 h after i.v. delivery of 2.0 mg/kg Photofrin II (Quadra Logic Technologies, Vancouver, British Columbia, Canada), and then escalating light doses of 30–32.5 J/cm2 after a 24-h sensitizer/operation interval. Twelve patients could not be debulked to the prerequisite 5 mm residual tumor thickness. The remaining 42 patients underwent 19 modified pleuropneumonectomies, five lobectomy-pleurectomies, and 18 pleurectomies. Intrapleural PDT was delivered using 630 nm light from two argon pump-dye lasers, and real-time and cumulative light doses were monitored using seven uniquely designed, computer-interfaced photodiodes.Results: There was one 30-day mortality from intraoperative hemorrhage. In the 48-h sensitizer/operation group (n=33), possible PDT-related complications included an empyema with late hemorrhage in one of three patients at 17.5 J/cm2 and a bronchopleural fistula at 35 J/cm2. At each of these light doses, three additional patients were treated without complication. Two patients subjected to 24-h sensitizer dosing and 32.5 J/cm2 developed esophageal perforations after pleuropneumonectomy at identical sites. The MTD was declared as 30 J/cm2 light with a 24-h dosing interval when none of the six patients (three original, three repeat) at that level developed toxicity.Conclusions: These data demonstrate that resection and intrapleural PDT can be performed safely with currently available sensitizers and lasers. Phase II and III trials are now warranted at this MTD in a homogeneous population of patients with pleural malignancies.
18 schema:genre article
19 schema:inLanguage en
20 schema:isAccessibleForFree false
21 schema:isPartOf N9d32ceac769444c3835beb288285477a
22 Nefffda1b3a704c18ae66465a8a6c4640
23 sg:journal.1105545
24 schema:keywords I trial
25 Intrapleural PDT
26 MTD
27 PDT
28 PDT-related complications
29 Photofrin II
30 additional patients
31 argon pump-dye lasers
32 available sensitizers
33 bronchopleural fistula
34 cm2
35 cm2 48 h
36 cm2 light
37 cohort
38 complex geometries
39 complications
40 computer-interfaced photodiodes
41 cumulative light doses
42 data
43 delivery
44 dose
45 dose/sensitizer interval
46 doses
47 dosimetry
48 empyema
49 esophageal perforation
50 feasibility
51 first order dosimetry
52 fistula
53 geometry
54 group
55 hemithorax pleural malignancy
56 hemorrhage
57 homogeneous population
58 identical sites
59 influence
60 intervals
61 intraoperative hemorrhage
62 intraoperative light doses
63 intrapleural photodynamic therapy
64 laser
65 late hemorrhage
66 levels
67 light
68 light dose/sensitizer interval
69 light doses
70 malignancy
71 management
72 maximal
73 mesothelioma
74 morbidity
75 mortality
76 neoplasms
77 operation group
78 operation interval
79 order
80 order dosimetry
81 patients
82 perforation
83 phase I trial
84 phase II
85 photodiodes
86 photodynamic therapy
87 photodynamic therapy (PDT) maximal
88 pleural malignancy
89 pleural neoplasms
90 pleurectomy
91 pleuropneumonectomy
92 population
93 possible PDT-related complications
94 postoperative morbidity
95 prerequisite
96 pump-dye lasers
97 resection
98 residual tumor thickness
99 results
100 sensitizer interval
101 sensitizer/operation group
102 sensitizer/operation interval
103 sensitizers
104 sites
105 surgery
106 therapy
107 therapy (PDT) maximal
108 thickness
109 toxicity
110 trials
111 tumor thickness
112 schema:name Intrapleural photodynamic therapy: Results of a phase I trial
113 schema:pagination 28-37
114 schema:productId N1ebd20bb50d14381845843b620928e09
115 N8ecdcd1db3bb43de8283c596722777b8
116 Na810454c8ec74901b3145bc0273dc1db
117 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003120273
118 https://doi.org/10.1007/bf02303538
119 schema:sdDatePublished 2022-01-01T18:05
120 schema:sdLicense https://scigraph.springernature.com/explorer/license/
121 schema:sdPublisher N9760cdcae020459c9debf3b396b94384
122 schema:url https://doi.org/10.1007/bf02303538
123 sgo:license sg:explorer/license/
124 sgo:sdDataset articles
125 rdf:type schema:ScholarlyArticle
126 N0eafb89b5b6d4f629f27d497bf32071b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Humans
128 rdf:type schema:DefinedTerm
129 N1ebd20bb50d14381845843b620928e09 schema:name doi
130 schema:value 10.1007/bf02303538
131 rdf:type schema:PropertyValue
132 N21e65edf873f4db0807a0feddc1aa783 rdf:first sg:person.012561650317.13
133 rdf:rest N7f26e82cd85b421b990eda6aaf435e22
134 N2a32bec6ac36445499fe926385323de3 rdf:first sg:person.011105000337.49
135 rdf:rest Nb069825038bb4bc2b2a32eb02109e4eb
136 N3964bade072e4d908dd84bd605567747 rdf:first sg:person.0763326335.92
137 rdf:rest N2a32bec6ac36445499fe926385323de3
138 N532dbe55ea1a4c47b03edbef9e57fbd9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Photochemotherapy
140 rdf:type schema:DefinedTerm
141 N6b93bafffc854b13a2f652638743cd9d rdf:first sg:person.01046205245.21
142 rdf:rest Nc6a3f23a533c456199d5b7e6fd595118
143 N6ceb4c3d510f41c398ae676c917f527d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Male
145 rdf:type schema:DefinedTerm
146 N73f80eb4a8424c36a12155a653aa6790 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Female
148 rdf:type schema:DefinedTerm
149 N77e52557da3345a394aca74a13dc3cfb rdf:first sg:person.07550762252.57
150 rdf:rest rdf:nil
151 N7850e9483cef440ca7d5fbc61b1ba4c0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Adult
153 rdf:type schema:DefinedTerm
154 N792e42a7daa741e2a7950aef666deef4 rdf:first sg:person.01032321717.09
155 rdf:rest N6b93bafffc854b13a2f652638743cd9d
156 N7f26e82cd85b421b990eda6aaf435e22 rdf:first sg:person.01306041342.14
157 rdf:rest Ndbc23e1cb8954ee1a67ad4297e364457
158 N8ecdcd1db3bb43de8283c596722777b8 schema:name pubmed_id
159 schema:value 7834425
160 rdf:type schema:PropertyValue
161 N971df54ff2954d56a8221fc300fa8cf2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Combined Modality Therapy
163 rdf:type schema:DefinedTerm
164 N9760cdcae020459c9debf3b396b94384 schema:name Springer Nature - SN SciGraph project
165 rdf:type schema:Organization
166 N9d32ceac769444c3835beb288285477a schema:issueNumber 1
167 rdf:type schema:PublicationIssue
168 Na810454c8ec74901b3145bc0273dc1db schema:name dimensions_id
169 schema:value pub.1003120273
170 rdf:type schema:PropertyValue
171 Nb069825038bb4bc2b2a32eb02109e4eb rdf:first sg:person.053570030.30
172 rdf:rest N21e65edf873f4db0807a0feddc1aa783
173 Nc57dc31b85b24840908e02f4cfe6691d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Aged
175 rdf:type schema:DefinedTerm
176 Nc584f38c3cb6415e9faf7cd72e149804 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Middle Aged
178 rdf:type schema:DefinedTerm
179 Nc6a3f23a533c456199d5b7e6fd595118 rdf:first sg:person.014401452607.09
180 rdf:rest Nfda2ea0c4cb64077b9bed4ada993528e
181 Ndbc23e1cb8954ee1a67ad4297e364457 rdf:first sg:person.01223477320.37
182 rdf:rest N792e42a7daa741e2a7950aef666deef4
183 Ndec3bc1ce30442748b0140b6c2568acd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
184 schema:name Survival Rate
185 rdf:type schema:DefinedTerm
186 Nea1acc095a354a209576c531a7afe760 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
187 schema:name Pleural Neoplasms
188 rdf:type schema:DefinedTerm
189 Neb573f6b0e36485fad30fd1f4ce6b601 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
190 schema:name Mesothelioma
191 rdf:type schema:DefinedTerm
192 Nefffda1b3a704c18ae66465a8a6c4640 schema:volumeNumber 1
193 rdf:type schema:PublicationVolume
194 Nf01290c85ee849c58bd842cb3a7cfa17 rdf:first sg:person.014251525642.48
195 rdf:rest N77e52557da3345a394aca74a13dc3cfb
196 Nfda2ea0c4cb64077b9bed4ada993528e rdf:first sg:person.01211242634.96
197 rdf:rest Nf01290c85ee849c58bd842cb3a7cfa17
198 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
199 schema:name Medical and Health Sciences
200 rdf:type schema:DefinedTerm
201 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
202 schema:name Clinical Sciences
203 rdf:type schema:DefinedTerm
204 sg:journal.1105545 schema:issn 1068-9265
205 1534-4681
206 schema:name Annals of Surgical Oncology
207 schema:publisher Springer Nature
208 rdf:type schema:Periodical
209 sg:person.01032321717.09 schema:affiliation grid-institutes:grid.48336.3a
210 schema:familyName Kranda
211 schema:givenName Karen C.
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01032321717.09
213 rdf:type schema:Person
214 sg:person.01046205245.21 schema:affiliation grid-institutes:grid.48336.3a
215 schema:familyName Russo
216 schema:givenName Angelo
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01046205245.21
218 rdf:type schema:Person
219 sg:person.011105000337.49 schema:affiliation grid-institutes:grid.48336.3a
220 schema:familyName DeLaney
221 schema:givenName Thomas F.
222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011105000337.49
223 rdf:type schema:Person
224 sg:person.01211242634.96 schema:affiliation grid-institutes:grid.94365.3d
225 schema:familyName Cole
226 schema:givenName John W.
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01211242634.96
228 rdf:type schema:Person
229 sg:person.01223477320.37 schema:affiliation grid-institutes:grid.48336.3a
230 schema:familyName Pogrebniak
231 schema:givenName Helen W.
232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01223477320.37
233 rdf:type schema:Person
234 sg:person.012561650317.13 schema:affiliation grid-institutes:grid.94365.3d
235 schema:familyName Smith
236 schema:givenName Paul E.
237 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012561650317.13
238 rdf:type schema:Person
239 sg:person.01306041342.14 schema:affiliation grid-institutes:grid.48336.3a
240 schema:familyName Temeck
241 schema:givenName Barbara K.
242 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01306041342.14
243 rdf:type schema:Person
244 sg:person.014251525642.48 schema:affiliation grid-institutes:grid.48336.3a
245 schema:familyName Mitchell
246 schema:givenName James B.
247 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014251525642.48
248 rdf:type schema:Person
249 sg:person.014401452607.09 schema:affiliation grid-institutes:grid.94365.3d
250 schema:familyName Friauf
251 schema:givenName Walter S.
252 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014401452607.09
253 rdf:type schema:Person
254 sg:person.053570030.30 schema:affiliation grid-institutes:grid.48336.3a
255 schema:familyName Tochner
256 schema:givenName Zelig
257 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.053570030.30
258 rdf:type schema:Person
259 sg:person.07550762252.57 schema:affiliation grid-institutes:grid.48336.3a
260 schema:familyName Thomas
261 schema:givenName Gunter
262 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07550762252.57
263 rdf:type schema:Person
264 sg:person.0763326335.92 schema:affiliation grid-institutes:grid.48336.3a
265 schema:familyName Pass
266 schema:givenName Harvey I.
267 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0763326335.92
268 rdf:type schema:Person
269 grid-institutes:grid.48336.3a schema:alternateName Radiation Oncology Branch and Experimental Phototherapy Section, National Cancer Institute, National Institutes of Health, USA
270 Thoracic Oncology Section, Surgery Branch, National Cancer Institute, National Institutes of Health, Building 10, Room 2B07, 20892, Bethesda, MD, USA
271 schema:name Radiation Oncology Branch and Experimental Phototherapy Section, National Cancer Institute, National Institutes of Health, USA
272 Thoracic Oncology Section, Surgery Branch, National Cancer Institute, National Institutes of Health, Building 10, Room 2B07, 20892, Bethesda, MD, USA
273 rdf:type schema:Organization
274 grid-institutes:grid.94365.3d schema:alternateName Biomedical Engineering and Instrumentation Program, National Center for Research Resources, National Institutes of Health, Bethesda, Maryland, USA
275 schema:name Biomedical Engineering and Instrumentation Program, National Center for Research Resources, National Institutes of Health, Bethesda, Maryland, USA
276 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...